LGT Group Foundation’s Boston Scientific BSX Stock Holding History

LGT Group Foundation’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$508K	Sell	11,905 -300,697	-96%	-$16.3M	0.01%	223
2026 Q1	$19.6M	Sell	312,602 -1,172	-0.4%	-$93.8K	0.24%	74
2025 Q4	$30.1M	Buy	313,774 +8,882	+3%	+$871K	0.33%	57
2025 Q3	$29.2M	Sell	304,892 -3,616	-1%	-$374K	0.33%	60
2025 Q2	$33.1M	Sell	308,508 -2,903	-0.9%	-$294K	0.42%	53
2025 Q1	$31.4M	Buy	311,411 +183,661	+144%	+$18.5M	0.43%	53
2024 Q4	$11.4M	Sell	127,750 -44,974	-26%	-$3.96M	0.18%	88
2024 Q3	$14.6M	Sell	172,724 -401,067	-70%	-$31.6M	0.24%	76
2024 Q2	$44.2M	Buy	573,791 +573,455	+170,671%	+$42M	0.7%	36
2024 Q1	$23K	Buy	+336	New	+$21.6K	﹤0.01%	249

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

LGT Group Foundation's BSX Position: Q2 2026 in Review

LGT Group Foundation reduced its Boston Scientific (BSX) stake by 96% in Q2 2026, selling an estimated $16.3M and leaving 11,905 shares worth $508K. The position accounts for 0.01% of the portfolio, ranked #223.

LGT Group Foundation first reported a position in BSX in Q1 2024 and has held it in 10 quarters since. The position peaked at $44.2M in Q2 2024. 1,487 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

LGT Group Foundation held 11,905 shares of Boston Scientific worth $508K as of Q2 2026.
LGT Group Foundation sold 300,697 Boston Scientific shares in Q2 2026, an estimated $16.3M.
Boston Scientific made up 0.01% of LGT Group Foundation's portfolio in Q2 2026, its #223 holding.
LGT Group Foundation first reported a position in Boston Scientific in Q1 2024 and has held it in 10 quarters since.
LGT Group Foundation's Boston Scientific position peaked at $44.2M in Q2 2024.
1,487 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on LGT Group Foundation's 13F filing for Q2 2026, filed 10 Aug 2026.